Table 7 Reporting in guidelines of trials of antihypertensive medication a
Triala | Yearb | CMA 1999 | WHO 1999 | VHA 1999 | SIGN 2001 | ESH 2003 | ICSI 2003 | JNC 2003 | SA 2003 | BHS 2004 | NICE 2004 |
|---|---|---|---|---|---|---|---|---|---|---|---|
VA-II[48] | 1970 | SR[49, 50] | SR[49,51] | SR[49,51,52] | SR[51] | SR[53] | SR[51] | SR[49] | ✓ | ||
HSCSG[54] | 1974 | SR[50] | SR[51] | SR[51] | SR[51] | SR[53] | SR[51] | ✓ | |||
USPHS[55] | 1977 | SR[50] | SR[51] | SR[51] | SR[51] | SR[53] | SR[51] | ✓ | |||
VA-NHLBI[56] | 1978 | SR[50] | SR[51] | SR[51] | SR[51] | SR[53] | SR[51] | ✓ | |||
HDFP[57-59] | 1979 | SR[49] | SR[49,51] | SR[49,51,52,60] | SR[51,61] | ✓ | ✓ | SR[51] | SR[49] | ✓ | |
ANBPS[62] | 1980 | SR[51] | SR[51,52,60] | SR[51,63] | SR | SR[51] | ✓ | ||||
EWPHE[64,65] | 1985 | SR[49,50] | SR[49,51,66] | ✓ | SR[51,61] | SR[53] | SR[51] | SR[49] | ✓ | ||
IPPPSH[67] | 1985 | ✓ | ✓ | ✓ | |||||||
MRC[68] | 1985 | SR[50] | ✓ | SR[51] | ✓ | SR[53] | SR[51] | ✓ | |||
Coope[69] | 1986 | SR[49] | SR[49,51,66] | ✓ | SR[51,61] | SR[53] | SR[51] | SR[49] | ✓ | ||
OSLO[70] | 1986 | SR[50] | SR[51] | SR[51] | SR[51] | SR[53] | SR[51] | ✓ | |||
SHEP-P[71-73] | 1986 | SR[50] | SR[60] | SR[61] | SR[53] | ✓ | |||||
HAPPHY[74] | 1987 | SR[50] | ✓ | ✓ | |||||||
MAPHY[75] | 1988 | ✓ | |||||||||
CAPPP[76,77] | 1990 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ||||
SHEP[78-81] | 1991 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | |||
STOP-H[82] | 1991 | SR[49] | ✓ | ✓ | SR[61] | ✓ | SR[53] | SR[49] | ✓ | ||
SYST-EUR[83-86] | 1991 | ✓ | ✓ | ✓ | SR[87] | ✓ | ✓ | ✓ | |||
MRC-O[88] | 1992 | SR[50] | ✓ | ✓ | SR[61] | ✓ | SR[53] | SR[49] | ✓ | ||
STOP-H2[89-91] | 1993 | SR[92] | ✓ | SR[63,87,93] | ✓ | ✓ | ✓ | ||||
NICS-EH[94,95] | 1994 | SR[92] | SR[63,87,93] | SR[63,96] | ✓ | ||||||
HOT[97] | 1995 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | |
PATS[98] | 1995 | ✓ | ✓ | ||||||||
ALLHAT[99,100] | 1996 | ✓ | ✓ | ✓ | ✓ | ✓ | |||||
MIDAS[101,102] | 1996 | SR[50,92] | ✓ | ✓ | SR[63] | ✓ | |||||
VHAS[103] | 1997 | SR[50,92] | ✓ | SR[3,87,93] | SR[63,96] | ✓ | |||||
ABCD[104] | 1998 | SR[92] | SR[87] | ✓ | ✓ | ✓ | ✓ | ||||
FACET[105] | 1998 | SR[92] | ✓ | ||||||||
UKPDS[106] | 1998 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ||
HOPE[107] | 2000 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | |||
INSIGHT[108,109] | 2000 | SR[92] | ✓ | ✓ | ✓ | ||||||
NORDIL[110] | 2000 | SR[92] | ✓ | ✓ | ✓ | ||||||
IDNT[111] | 2001 | SR[93] | SR[96] | ✓ | |||||||
PROGRESS[112] | 2001 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | |||
RENAAL[113] | 2001 | ✓ | ✓ | ||||||||
ELSA[114] | 2002 | SR[93] | SR[96] | ||||||||
LIFE[115] | 2002 | ✓ | ✓ | ✓ | ✓ | ||||||
ANBP2[116,117] | 2003 | SR[93] | ✓ | SR[96] | ✓ | ||||||
CONVINCE[118,119] | 2003 | ✓ | ✓ | SR[96] | ✓ | ||||||
SCOPE[120] | 2003 | ✓ | SR[96] | ✓ | |||||||
JMIC-B[121] | 2004 | SR[96] | |||||||||
VALUE[122-124] | 2004 | ✓ |